White paper

Communicating with HCPs based on their observed prescribing behavior

Because of our extensive EHR and pharmacy networks, ConnectiveRx has the unique ability to observe prescribing behavior and deliver messages that matter directly to a prescriber’s inbox from a trusted sender. This method of identifying high-value prescribers can substantially increase the impact of your brand’s campaigns. And our ability to compare observed behaviors before and after your campaign is delivered helps you more accurately measure its impact.

Read compelling data on the effect of PREVIEW pane readership on traditional email results. Our case studies reveal significant message recall and engagement that did not correspond to traditionally recorded email opens and clicks.

Key findings include:

1. Targeting prescribers based on observed prescribing behavior delivered greater impact than traditional targeting
2. Viewing in the PREVIEW pane added 30% to readership
3. “Email from PDR” was (by far) the most preferred digital channel

We encourage brand marketers to consider both traditional and behavior-based targeting. While delivering information to your internal target list can be effective, communicating information that really matters to those who are actively prescribing your brand or a drug in its class will add power to your message. Read the white paper to learn more.

About ConnectiveRx Market Research
ConnectiveRx market research is conducted among our proprietary PDR panel of over 695,000 healthcare professionals comprised of MDs, DOs, NPs and PAs in over 300 specialties and subspecialties, as well as pharmacists. PDR’s 70+ year history of trust and value enables us to engage and conduct timely market research, and bring important insights to our clients and channel partners.